121 related articles for article (PubMed ID: 36121076)
1. MicroRNA Gene Signature for Predicting Mechanisms in Nasopharyngeal Carcinoma: A Case Study on the Potential Application of Circulating Biomarkers.
Wardana T; Oktriani R; Murjayanto CH; Putri DU; Anwar SL; Aryandono T; Haryana SM
Microrna; 2023; 12(1):29-44. PubMed ID: 36121076
[TBL] [Abstract][Full Text] [Related]
2. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
[TBL] [Abstract][Full Text] [Related]
3. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
[TBL] [Abstract][Full Text] [Related]
4. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma.
Lu T; Guo Q; Lin K; Chen H; Chen Y; Xu Y; Lin C; Su Y; Chen Y; Chen M; Zheng Y; Ye Y; Lin S; Zong J; Pan J
Cancer Sci; 2020 May; 111(5):1711-1723. PubMed ID: 32155300
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W
Gene; 2020 Feb; 727():144243. PubMed ID: 31743768
[TBL] [Abstract][Full Text] [Related]
6. A panel of three serum microRNA can be used as potential diagnostic biomarkers for nasopharyngeal carcinoma.
Li R; Lu C; Yang W; Zhou Y; Zhong J; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Hu H; Lai Y
J Clin Lab Anal; 2022 Feb; 36(2):e24194. PubMed ID: 35028969
[TBL] [Abstract][Full Text] [Related]
7. Circulating Epstein-Barr virus microRNA profile reveals novel biomarker for nasopharyngeal carcinoma diagnosis.
Wu L; Wang J; Zhu D; Zhang S; Zhou X; Zhu W; Zhu J; He X
Cancer Biomark; 2020; 27(3):365-375. PubMed ID: 31958073
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
Jiang C; Chen J; Xie S; Zhang L; Xiang Y; Lung M; Kam NW; Kwong DL; Cao S; Guan XY
Int J Cancer; 2018 Dec; 143(12):3209-3217. PubMed ID: 29971780
[TBL] [Abstract][Full Text] [Related]
9. miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma.
Jiang L; Zhang Y; Li B; Kang M; Yang Z; Lin C; Hu K; Wei Z; Xu M; Mi J; Wang R; Wu F
Cancer Sci; 2021 Jun; 112(6):2393-2404. PubMed ID: 33728743
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of microRNA regulatory network in nasopharyngeal carcinoma with deep sequencing.
Wang F; Lu J; Peng X; Wang J; Liu X; Chen X; Jiang Y; Li X; Zhang B
J Exp Clin Cancer Res; 2016 Jan; 35():17. PubMed ID: 26795575
[TBL] [Abstract][Full Text] [Related]
11. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
Cui Z; Zhao Y
BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
[TBL] [Abstract][Full Text] [Related]
12. FOXD1, negatively regulated by miR-186, promotes the proliferation, metastasis and radioresistance of nasopharyngeal carcinoma cells.
Zhang Y; Zhang W
Cancer Biomark; 2020; 28(4):511-521. PubMed ID: 32568181
[TBL] [Abstract][Full Text] [Related]
13. Plasma microRNA expression signature involving miR-548q, miR-630 and miR-940 as biomarkers for nasopharyngeal carcinoma detection.
Zhuo X; Zhou W; Li D; Chang A; Wang Y; Wu Y; Zhou Q
Cancer Biomark; 2018; 23(4):579-587. PubMed ID: 30475754
[TBL] [Abstract][Full Text] [Related]
14. Circulating miR-31-5p may be a potential diagnostic biomarker in nasopharyngeal carcinoma.
Yi SJ; Liu P; Chen BL; Ou-Yang L; Xiong WM; Su JP
Neoplasma; 2019 Sep; 66(5):825-829. PubMed ID: 31129965
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis.
Lu J; Xu X; Liu X; Peng Y; Zhang B; Wang L; Luo H; Peng X; Li G; Tian W; He M; Li X
Br J Cancer; 2014 Jan; 110(2):392-8. PubMed ID: 24327016
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
Huang Q; Hou S; Zhu X; Liu S
World J Surg Oncol; 2020 Feb; 18(1):29. PubMed ID: 32013999
[TBL] [Abstract][Full Text] [Related]
17. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
[TBL] [Abstract][Full Text] [Related]
18. Circulating miR-214-3p predicts nasopharyngeal carcinoma recurrence or metastasis.
Wang J; Xu Y; Wang J; Ying H
Clin Chim Acta; 2020 Apr; 503():54-60. PubMed ID: 31926154
[TBL] [Abstract][Full Text] [Related]
19. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
[TBL] [Abstract][Full Text] [Related]
20. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma.
Luo Z; Zhang L; Li Z; Li X; Li G; Yu H; Jiang C; Dai Y; Guo X; Xiang J; Li G
BMC Med Genomics; 2012 Jan; 5():3. PubMed ID: 22260379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]